Procter & Gamble Hygiene and Health Care Limited — PPTs, 16-06-2026: Investor Presentation

Procter & Gamble Hygiene and Health Care (PGHH) reported flat sales for FY25-26, but its Profit After Tax (PAT) climbed 19%. This comparison is against a comparable 12-month period due to a fiscal year change. Over the past decade, PGHH has shown strong performance, with Net Sales growing at a 6% CAGR and PAT at an 8% CAGR, significantly boosting Return on Equity.

The company's core growth strategy focuses on "Superiority" across products, packaging, communication, and retail execution to capture consumer preference. It also emphasizes "Portfolio" performance and "Productivity" to fuel investments, achieving INR 86 Cr in productivity savings in FY25-26. PGHH is also embracing "Constructive Disruption" by investing in data and AI platforms for operational efficiency.

Looking ahead, management aims to grow faster than the market, improve margins, and maintain financial prudence. While India's economic growth outpaces global peers, the company observes soft consumption trends in both rural and urban markets, with muted core inflation but potential watch on energy inflation.